Document is current
Any future updates will be listed below
-
Authors
Liang, Qiansheng https://orcid.org/0009-0009-0856-1957
Chi, Gamma https://orcid.org/0000-0001-9910-0965
Cirqueira, Leonardo https://orcid.org/0000-0001-7335-174X
Zhi, Lianteng
Marasco, Agostino https://orcid.org/0009-0008-6875-653X
Pilati, Nadia
Gunthorpe, Martin J. https://orcid.org/0000-0002-0216-1735
Alvaro, Giuseppe
Large, Charles H. https://orcid.org/0000-0001-9814-7737
Sauer, David B. https://orcid.org/0000-0001-9291-4640
Treptow, Werner https://orcid.org/0000-0003-4564-3205
Covarrubias, Manuel https://orcid.org/0000-0002-0881-4143
-
Funding
Funding for this research was provided by:
Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (200114/2020-4)
Wellcome Trust (106169/Z/14/Z)
Innovative Medicines Initiative (875510)
- License Information
-
More Information
Article History
Received: 10 April 2023
Accepted: 11 March 2024
First Online: 21 March 2024
Competing interests
: A.M., N.P., G.A., M.J.G. and C.H.L. are employees and shareholders of Autifony Therapeutics, Ltd. Q.L., L.Z. and M.C. received funding from Autifony Therapeutics, Ltd. to conduct this work. The remaining authors declare no competing interests.
